Biofrontera Biofrontera
  1. Biofrontera
  2. Investors & Media
  3. Corporate governance
  4. Statement of corporate governance

Statement on Corporate Governance

In the Corporate Governance Statement pursuant to Section 289f of the German Commercial Code (HGB) and the Group Corporate Governance Statement pursuant to Section 315d of the German Commercial Code (HGB), the Executive Board and Supervisory Board provide information on the most important components of corporate governance. In addition to the annual Declaration of Conformity pursuant to Section 161 of the German Stock Corporation Act (AktG), they include relevant disclosures on corporate governance practices as well as other aspects of corporate governance such as, in particular, a description of the working methods of the Executive Board and Supervisory Board.

 

Corporate Governance Statement of Biofrontera AG pursuant to Sections 289f, 315d HGB for the financial year 2023 (PDF)

Corporate Governance Statement of Biofrontera AG pursuant to Sections 289f, 315d HGB for the financial year 2022 (PDF)

Corporate Governance Statement of Biofrontera AG pursuant to Sections 289f, 315d HGB for the financial year 2021 (PDF)

Corporate Governance Statement of Biofrontera AG pursuant to Sections 289f, 315d HGB for the financial year 2020 (PDF)

Corporate Governance Statement 2019 (PDF)

Corporate Governance Statement 2018 (PDF)

Corporate Governance Statement 2017 (PDF)

Corporate Governance Statement 2016 (PDF)

Corporate Governance Statement 2015 (PDF)

Corporate Governance Statement 2014 (PDF)